Terms: = Ovarian cancer AND PER1, O15534, 5187, ENSG00000179094, RIGUI
5 results:
1. Prognostic risk factors of serous ovarian carcinoma based on mesenchymal stem cell phenotype and guidance for therapeutic efficacy.
Yang X; Zheng M; Ning Y; Sun J; Yu Y; Zhang S
J Transl Med; 2023 Jul; 21(1):456. PubMed ID: 37434173
[TBL] [Abstract] [Full Text] [Related]
2. The circadian rhythm and core gene Period2 regulate the chemotherapy effect and multidrug resistance of ovarian cancer through the PI3K signaling pathway.
Wang Z; Wang H; Guo H; Li F; Wu W; Zhang S; Wang T
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33083827
[TBL] [Abstract] [Full Text] [Related]
3. Clock genes and cancer development in particular in endocrine tissues.
Angelousi A; Kassi E; Ansari-Nasiri N; Randeva H; Kaltsas G; Chrousos G
Endocr Relat Cancer; 2019 Jun; 26(6):R305-R317. PubMed ID: 30959483
[TBL] [Abstract] [Full Text] [Related]
4. Influence of the estrous cycle on clock gene expression in reproductive tissues: effects of fluctuating ovarian steroid hormone levels.
Nakamura TJ; Sellix MT; Kudo T; Nakao N; Yoshimura T; Ebihara S; Colwell CS; Block GD
Steroids; 2010 Mar; 75(3):203-12. PubMed ID: 20096720
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer.
Tokunaga H; Takebayashi Y; Utsunomiya H; Akahira J; Higashimoto M; Mashiko M; Ito K; Niikura H; Takenoshita S; Yaegashi N
Acta Obstet Gynecol Scand; 2008; 87(10):1060-70. PubMed ID: 18720043
[TBL] [Abstract] [Full Text] [Related]
